The store will not work correctly when cookies are disabled.
(2E)-3-(5-Methoxy-1H-indol-3-yl)-N-(prop-2-yn-1-yl)prop-2-enamide
ID: ALA4781688
PubChem CID: 162664134
Max Phase: Preclinical
Molecular Formula: C15H14N2O2
Molecular Weight: 254.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C#CCNC(=O)/C=C/c1c[nH]c2ccc(OC)cc12
Standard InChI: InChI=1S/C15H14N2O2/c1-3-8-16-15(18)7-4-11-10-17-14-6-5-12(19-2)9-13(11)14/h1,4-7,9-10,17H,8H2,2H3,(H,16,18)/b7-4+
Standard InChI Key: XQWAYIDPXUATOJ-QPJJXVBHSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
39.3682 -26.4431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3671 -27.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0751 -27.6716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0733 -26.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7819 -26.4395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7822 -27.2581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5609 -27.5109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.0419 -26.8484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5604 -26.1864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6604 -26.0347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.9528 -26.4435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8127 -25.4091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.6120 -25.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8642 -24.4616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6635 -24.2915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.3172 -23.8545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.2105 -24.8986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0098 -24.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.8060 -24.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
10 11 1 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 3 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 254.29 | Molecular Weight (Monoisotopic): 254.1055 | AlogP: 1.94 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.72 | CX LogD: 1.72 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.65 | Np Likeness Score: -0.62 |
References
1. Herrera-Arozamena C,Estrada-Valencia M,Pérez C,Lagartera L,Morales-García JA,Pérez-Castillo A,Franco-Gonzalez JF,Michalska P,Duarte P,León R,López MG,Mills A,Gago F,García-Yagüe ÁJ,Fernández-Ginés R,Cuadrado A,Rodríguez-Franco MI. (2020) Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties., 190 [PMID:32018096] [10.1016/j.ejmech.2020.112090] |